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There is evidence for an unexpected role of diferric transferrin as a terminal oxidase for the transplasma membrane oxidation of
cytosolic NADH. In the original studies which showed the reduction of iron in transferrin by the plasma membranes NADH
oxidase, the possible role of the reduction on iron uptake was emphasized. The rapid reoxidation of transferrin iron under
aerobic conditions precludes a role for surface reduction at neutral pH for release of iron for uptake at the plasma membrane.
The stimulation of cytosolic NADH oxidation by diferric transferrin indicates that the transferrin can act as a terminal oxidase
for the transplasma membrane NADH oxidase or can bind to a site which activates the oxidase. Since plasma membrane NADH
oxidases clearly play a role in cell signaling,the relation offerric transferrin stimulationofNADH oxidaseto cell control should be
considered, especially in relationto thegrowth promotionbytransferrin notrelated to ironuptake. The oxidasecanalsocontribute
to control of cytosolic NAD concentration, and thereby can activate sirtuins for control of ageing and growth.
1.Introduction
The remarkable diversity of oxidative activity at the plasma
membrane has only recently been brought into focus. Early
study of peroxide generation in cells emphasized the role
of mitochondria in relation to free radical generation [1,
2]. Other sources of H2O2 such as xanthine oxidase [3],
monoamine oxidase [1], or disulﬁde bond formations [4]
have been recognized, but attributed a lesser role. In the
plasma membrane the controlled generation of H2O2 by
leucocytes to ﬁght infection is well established [5, 6]. More
recently, the H2O2 generating capacity in plasma membrane
of other types of cells has been recognized and proposed
to be the basis for hormone and growth factor response,
oxygen sensing [7], and microbicidal action [8–12]. These
H2O2 generatingsystemshaveallbeenrelatedtotheNADPH
o x i d a s eG P 9 1p h o xG p 2 2p h o xe n z y m e sﬁ r s tr e c o g n i z e d
in neutrophils [5, 6]. Seven variations of this NADPH
oxidase have been found and are designated as NOX1-5
and Duo NOX1-2 [9, 13]. The reaction with oxygen in all
is catalyzed by the oxidation of low-potential cytochrome
b 558. The members of the NOX groups are individually
expressed in diﬀerenttissues [9, 12]. Plasma membranes also
have NADH oxidase activity [14–16]. Two forms of NADH
oxidase have been extracted from plasma membranes and
designated cNOX and tNOX [17]. These oxidases do not use
cytochrome b558 as a terminal link to oxygen. The isolated
enzyme also acts as a ubiquinol oxidase [18, 19]w h i c hm a y
representitsphysiologicalfunction intheplasmamembrane.
It could oxidize ubiquinol in the plasma membrane formed
by reduction of ubiquinone from cytosolic NADH through
NADH cytochrome b5 reductase [20, 21]. The activation of
the NADH oxidase by diferric transferrin and the relation to
cellular control are the subjects of this paper.
2.Plasma Membrane RedoxSystems
Plasma membranes isolated from rat liver or adipocytes
haveNADHoxygenoxidoreductaseactivity(NADHoxidase)
[14,21].Thisoxidaseactivityisnotinhibitedbyagentswhich
inhibit NADH oxidase activity in mitochondria [15, 22]a n d
is stimulated by diferric transferrin [23]. How this oxidase
activityisrelatedtootherredoxactivityinplasmamembrane
remains to be established.
In addition to stimulation by diferric transferrin, the
NADH oxidase of rat liver plasma membrane is stimulated
by insulin and epidermal growth factor (EGF) [15]. Both2 Biochemistry Research International
the endogenous NADH oxidase and the diferric transferrin-
stimulated NADH oxidase are stimulated by coenzyme Q10
and are inhibited by coenzyme Q analogs such as piericidin
A[ 15, 21]. Thus, the diferric transferrin stimulated oxidase
may require the reduced coenzyme Q oxidase (tNOX) [18,
24] and one of the known NADH dehydrogenases in the
plasma membrane for the complete electron transfer chain
from NADH to oxygen [19, 20, 25]. Diferric transferrin
would be a terminal link to oxygen or can act to increase the
reaction with oxygen. There are two NADH dehydrogenases
which have been recognized in the plasma membrane. These
a r e( A )t h eN A D Hc y t o c h r o m eb 5 reductase [20]a n d( B )
the NQ 0-1 (DT diaphorase) [26]w h i c hc a no x i d i z eb o t h
NADH and NADPH. Both of these NADH dehydrogenases
can reduce coenzyme Q in the plasma membrane. The
occurrence of these dehydrogenases may vary in diﬀerent
plasma membranes [20, 27]. In membranes where either one
is present, they would be expected to function in any NADH
oxidase system using coenzyme Q and reduced coenzyme
Q oxidase to transfer electrons across the membrane. The
transfer of electrons to oxygen in the unsupplemented
plasma membrane can best be based on the activity of the
reduced coenzyme Q oxidase [18]. At this time, the mecha-
nism of reaction and the prosthetic groups involved are not
known. There is also evidence for an iron site on the outer
surface of theplasma membrane. This site is basedon extrac-
tion of iron from the exterior of cells by the impermeable
chelator bathophenanthroline disulfonate (BPS). Extraction
of iron by BPS inhibits ferricyanide reduction outside the
cell, but it is not known if the extraction inhibits oxidase
activity [28]. An additional enzyme in plasma membrane
which can act as an NADH dehydrogenase is the VDAC
pore complex. This enzyme catalyzed NADH ferricyanide
reductase activity, but it is not known if it can act as an
oxidase or contribute to NADH oxidase activity [25].
3.EvidenceforDiferricTransferrinAs
anElectronAcceptor
The stimulation of the plasma membrane NADH oxidase
activity by diferric transferrin opens the possibility for
am o r ee ﬃcient terminal link to oxygen. There is good
evidence that the Fe2Tf can act as a terminal oxidase with
liver plasma membrane. Two methods have been used to
show that diferric transferrin can be reduced by NADH
at the plasma membrane [23]. One is by direct measure
of the decrease in absorbance of the diferric transferrin at
465nm when diferric transferrin is in the presence ofNADH
and isolated plasma membrane. The reduction occurs only
in absence of air, and the diferric transferrin absorbance
returns immediately when air is admitted [29]. This shows
that NADH and plasma membrane can reduce the iron in
diferric transferrin anaerobically and that the iron is rapidly
reoxidized in the presence of oxygen [23]. The absorbance
at 465nm is characteristic of diferric transferrin [30]. The
second assay for reduction of diferric transferrin by NADH
and plasma membrane measures the formation of ferrous
bathophenanthroline disulfonate (BPS) at 535nm [23]. This
procedure has also been used to show diferric transferrin
reduction at the surface of several diﬀerent types of cells
[31–34]. The use of BPS to show the reduction of iron in
diﬀeric transferrin has been objected to onthe basis that BPS
eﬀectively raises the redox potential of the ferric transferrin
so that it can be reduced by NADH [35]. This is true since
the BPS would stabilize the ferrous iron and prevent its
reoxidation to ferric byrebinding to the transferrin. The BPS
eﬀect would be similar to keeping the iron under anaerobic
conditions. The assay does show that electrons from NADH
can cross the plasma membrane to reduce the iron in
diferric transferrin. Under aerobic conditions without the
chelator the ferrous iron would be immediately reoxidized
by oxygen to recombine with transferrin and therefore
would not be available for transport into the cell as ferrous
iron. Thorstensen and Romslo [36]h a v em a d ea ne x t e n s i v e
analysis of the relation of the redox system and iron
uptake and conclude that at least for hepatocytes the redox
system appears to contribute to iron uptake. They point out
that anaerobic conditions favor iron uptake by liver cells
which is consistent with the eﬀect of argon on the rate of
formation of ferrous BPS by liver or HeLa cells incubated
with diferric transferrin [37, 38]. Argon increases the rate
of ferrous BPS formation by 59% with HeLa cells and by
25% with liver cells. The reduction of ferric ammonium
citrate (FAC) is not stimulated under argon [38]w h i c hi s
consistent with much slower reoxidation of ferrous iron not
associated with transferrin. The assay of NADH oxidation in
the presence of diferric transferrin and plasma membrane
provides acorollary to the direct assays of diferric transferrin
reduction. The rate of NADH oxidation is increased by
addition of diferric transferrin to the plasma membrane.
This is consistent with a rapid transfer of electrons to oxygen
through diferric transferrin reduction and reoxidation. The
stimulation is quite speciﬁc for NADH oxidation. With
rat liver plasma membranes, diferric transferrin stimulated
NADH oxidase 60% and NADPH oxidase 14% [15, 23].
The stimulation was inhibited by the GB16 antibody to the
transferrin receptor [39], but increased transferrin receptor
in tumor cells does not necessarily increase stimulation [40]
which indicates that the transferrin receptor itself is not
alone suﬃcient to act as an oxidase. Diferric lactoferrin is
not involved in iron uptake, but is eﬀective in stimulation
of cell growth [41, 42]. Diferric lactoferrin also stimulates
rat liver plasma membrane NADH oxidase. In a preparation
where diferric transferrin stimulated NADH oxidase 73%
diﬀericlactoferrin stimulated 80%.Forboth, the stimulation
is inhibited by the transferrin or lactoferrin antibody [33],
respectively. Assay with isolated plasma membrane does not
show orientation of the enzyme, so the oxidation of internal
NADH was measured using whole cells.
4.Evidencefora Transmembrane Oxidase
The transmembrane nature of the transferrin-stimulated
oxidase can be demonstrated by measuring the cellular con-
centration of NADH. The oxidation of NAD(P)H in intact
K562 cells is seen in the decrease of absorbance at 340nm
when diferric transferrin is added to the cells [34]. This
shows that the reduced pyridine nucleotides are oxidized. ByBiochemistry Research International 3
using a speciﬁc enzymatic assay for NADH, the decrease in
HeLa cells on addition of diferric transferrin has been shown
[43, 44]. The evidence that addition of diferric transferrin
to cells stimulates the immediate oxidation of internal
NADH indicating that reduction and reoxidation of diﬀeric
transferrin on the outside of cells can catalyse oxidation
of internal NADH. Inhibition of the transferrin stimulated
NADH oxidase by inhibitors of the coenzyme Q pathway
is further evidence that the coenzyme Q requiring NADH
oxidase is the major site of transferrin stimulation. Capsaicin
inhibits diferric transferrin reductase 88% [21], whereas
the transmembrane electron transport in neutrophils is not
inhibited by the capsaicin analog resiniferatoxin [45]. The
coenzyme Q analog piericidin also inhibits rat liver plasma
membrane transferrin stimulated NADH oxidase, and the
inhibition is partially reversed by coenzyme Q [46].
5.The RedoxSystemInvolved in
TransferrinReduction
With liver plasma membrane, addition of Fe2Tf increases
oxidation of both NADH and NADPH. The increase is
greater during oxidation of NADH compared to NADPH
[15, 23]. There is evidence that oxygen is the terminal
acceptor since there is no net reduction of ferric transferrin
under aerobic conditions. NADPH has not been tested as an
electron donor under anaerobic conditions. Also unknown
is which of the transplasma membrane oxidase systems is
responsible for the transferrin stimulated oxidation. With
liverplasma membrane thedehydrogenase involvedisappar-
ently one of the enzymes which requires coenzyme Q as
shown by reversible decrease in activity after extraction of
CoQ. This would involve either the NADH cytochrome b5
reductase or the NADH/NADPHDT diaphorase [26]. There
is a report that VDAC-1 can also act as a NADH CoQ
reductase so that it is not excluded from a role in transferrin
stimulated oxidase [25]. Since there is no evidence that the
NADPH oxidase of the NOX1-5 series requires coenzyme Q
it is unlikely that they function as the primary transferrin
reductase in liver membranes. However it is possible that
they transfer electrons through the low-potential cyt b558 to
diferrictransferrin. Also,itshould benotedthatnotall ofthe
Fe2Tf-stimulated oxidase was lost after CoQ extraction. The
residual activity could be based on NOX-3 which has been
identiﬁed in liver [47]. The components of the transferrin
stimulated NADH oxidase are shown in Figure 1.
6.AdventitiousIron
In studies before 1988, we found considerable variation in
therateofdiferrictransferrin reductionwithdiﬀerentprepa-
rations of diferric transferrin. Measurement of adventious
loosely bound iron using ascorbate as a reductant and BPS
to measure formation of ferrous BPS showed that the most
active preparations contained up to 1u mole of loosely
bound iron [37] per u mole transferrin. After 1988, diferric
transferrin was checked for adventious iron [31, 33, 37]. All
theassay proceduresdone after1988with diferric transferrin
tested for adventious iron show signiﬁcant reduction of
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Figure 1: Diagram of plasma membrane redox involved in ferric
transferrin reduction [15, 37, 48].
the diferric transferrin or stimulation of NADH oxidase
although the rates are clearly higher if extra iron is present.
This is consistent with the stimulation of reduction when
ferric ammonium citrate is added along with transferrin as
shown in Table 2 [31]. An involvement of the transferrin
receptor in activation of the iron reduction may be indicated
since the rate with transferrin present can increase over the
rate with the same amount of iron [31].
The direct spectrophotometric assay of diferric transfer-
rin reduction by NADH with liver plasma membrane would
not be inﬂuenced by adventious iron [23]. The inhibition
of diferric transferrin reduction by apotransferrin may also
be attributed partly to binding of adventious iron to the
apotransferrin, since apotransferrin does not always bind
strongly to the transferrin receptor [54]. The stimulation of
plasma membrane NADH oxidation by diﬀerent prepara-
tions of diferric transferrin is shown in Table 1.T h ea m o u n t
of adventious iron was not measured before 1988 so the
higherratesprobablyreﬂect thepresenceofexcessiron.After
1988, the diferric transferrin was tested for extra iron by the
ascorbate reduction test.
These preparations show a more consistent low rate of
stimulation. The eﬀect of NAD(P)H oxidase stimulation by
diferric transferrin (withoutextrairon) canbedemonstrated
by direct spectrophotometric measurement of decrease of
NAD(P)H in K562 cells at 340nm when diferric transferrin
is added to the cells [34].
7.Functionofthe Oxidase
The overall eﬀects of diferric transferrin stimulation of
the plasma membrane NADH oxidase may be encountered
both inside and outside the cells. Inside the oxidation,
stimulation can shift the redox poise of the cell by oxida-
tion of the reduced pyridine nucleotide [34]a n di n c r e a s e
NAD concentration. Outside, transferrin may introduce an4 Biochemistry Research International
Table 1: Stimulation of NADH oxidase of rat liver plasma membrane by diferric transferrin (Fe2Tf) with control of adventious iron in the
Fe2Tf.
Year of publication Fe2Tf Concentration
micromolar Extra Fe NADH oxidase Stimulation n
mole min ￿1mgprotein−1 References
1986 3.4 ? 3.0 [31]
1987 3.4 ? 2.6 + 0.3 [49]
1987 10 ? 7.4 + 0.2 [44]
1987 17 ? 17 [42]
1990 3.5 ? 5.4 [50]
1990 10 NO 0.77 + 0.07 [51]
1991 3 NO 0.9 [8]
1991 10 NO 0.5 [23]
1991 17 NO 1.1 [52]
1992 3.4 NO 2.0 [26]
1992 17 NO 4.5 [26]
1992 12.5 NO 0.91 [53]
Table 2: Eﬀect of diferric transferrin on the rate of iron reduction
with ferric ammonium citrate (FAC) by SV403T3 cells. Assay with
diﬀeric transferrin Fe2Tf tested for presence of adventious iron.
Data from reference [31].
Micromolar additions Rate of iron reduction (FeBPS formation)
n mole mm−1 cells × 10−6
FAC 7.5 0.4
Fe2Tf 28 0.6
FAC + Fe2Tf 1.9
alternative source of superoxide by one-electron transfer
from ferrous iron to oxygen. Oxidation of NADH by the
endogenous oxidase in absence of transferrin is reported not
to generate superoxide [24, 55]. A low level of hydrogen
peroxide generation by NADH oxidation with liver plasma
membranes has been observed [56], but the rate of H2O2
production was only 3 percent of the rate of oxygen uptake
with NADH. The rate of NADPH oxidation which could be
a measure of NOX activity was less than 10 percent of the
NADH, oxidase but was associated with 50 percent H2O2
production.
Superoxide production from NADH at the cell surface
can be stimulated by ultraviolet light [57] or phenazine me-
thosulfate [45]. The eﬀect of diferric transferrin on superox-
ide production at the surface of cells needs to be determined.
Stimulation of the oxidase or transfer of electrons
through transferrin iron may increase surface superoxide
productionaboveany productionbytheendogenousoxidase
in absence of diferric transferrin.
A further important function activated by the diferric
transferrin is the release of protons from the cells either in
conjunction with electron transport or by stimulation of
the Na+/H+antiport. Part of the stimulated proton release
is inhibited by amiloride inhibitors of the antiport, and a
small part is not inhibited and is stoichiometric to electron
transport [33, 50, 58]. Activation of the antiport increases
the internal pH and increases membrane potential [38]. The
oxidase also controls the concentration of cytosolic NAD
which can activate sirtuin that controls metabolic functions
[59, 60].
The transferrin stimulated transplasma membrane
NADH oxidase may also be involved in control of reactive
oxygen species generated in hyperglycaemia or with excess
ethanol. Although there are multiple mechanisms involved
in hyperglycaemic damage, one aspect is the generation
of reactive oxygen species from glycolytic NADH [61].
The major source of ROS based on high glucose in both
adipocytes and endothelial cel l si sm i t o c h o n d r i a lp y r u v a t e
as indicated by inhibitors. NADH generated by glycolysis in
the cytosol did not contribute which suggests that cytosolic
NADHis oxidized by the plasma membrane oxidase without
generation of ROS [59] .T h ep r e s e n c eo fc o p p e ri nt h e
oxidase would be consistent with a complete reduction of
oxygen to water [48].
On the other hand, in adipocytes, Wu et al. [11]s h o w
that the NADH/NADPHoxidase inhibitor diphenyleneiodo-
nium strongly inhibits glucose-stimulated ROS production
which suggests inhibition of the plasma membrane oxidase
decreases glucose-stimulated ROS generation. With excess
ethanol, cells with alcohol dehydrogenase would produce
excess cytosolic NADH which would be available for oxida-
tion by the plasma membrane oxidase. Diferric transferrin
would increase the oxidation of cytosolic NADH [43]w h i c h
would lead to formation of ROS if the ferrous iron is reoxi-
dized by a one-electron transfer to oxygen. Thus, the extent
of diferric stimulation of the oxidase may inﬂuence the
damaging eﬀects of excess ethanol. Cells respond to hypoxia
by preventingthe prolyl hydroxylase-catalyzed breakdown of
the transcription factor HIF-1α[49]. The diferric transferrin
stimulated NADH oxidase may inﬂuence the response to
mild hypoxia. Generation of ROS decreases ferrous iron to
decrease the activity of prolylhydroxylase to decrease the
breakdown of HIF-1α which would increase the response
to mild hypoxia [53]b yp r e s e r v i n gH I F - 1 α. Oxidation of
cytosolic NADH by the plasma membrane oxidase should
decrease mitochondrial generation of cytosolic ROS to allowBiochemistry Research International 5
increasedHIF-1αbreakdown.Inhibitionoftheplasmamem-
brane oxidase should decrease loss of HIF-1α. Inﬂuence on
the level of HIF-1α can be important in vital gene regulation
and tumor control [52].
Eﬀects on redox state may be enhanced if extra iron is
present in the form of ferric citrate since it is clear that extra
iron in addition to the two tightly bound atoms in diferric
transferrin can further stimulate the plasma membrane
oxidase.
Two questionsremain unanswered. (A)Does reoxidation
of the reduced iron during rebinding to transferrin produce
superoxide?and (B)howdofunctions activated by the trans-
fer of electrons to transferrin aﬀect cell growth or survival
[62] and is transferrin stimulation of cell growth based, at
least in part, on stimulation of the plasma membrane NADH
oxidase?
8.Conclusions
Plasma membrane NADPH oxidases are clearly important
to plasma membrane signal transduction. Since the plasma
membrane NADH oxidase also responds to growth factors
like EGF, it may also have a role in signaling. The diferric
transferrin stimulation of the NADH oxidase got lost in the
discussion of its possible relation toiron uptake.The relation
of this transferrin stimulation to the growth stimulation by
transferrin remains to be examined. It is likely to play a
uniquerolesinceferriclactoferrinwhich doesnotparticipate
in iron uptake has also been eﬀective in growth stimulation
and in NADH oxidase stimulation. The ferric transferrin
stimulation of the oxidase also decreases cytosolic NADH
andstimulatestheNa+/H+ antiportwhich canrelatetosignal
transduction in addition to possible superoxide generation
basedonthereoxidationofthetransferrin iron.Theactionof
excess iron associated with transferrin in further stimulation
of the oxidase may relate to problems of iron overload.
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